Novartis sees Sandoz adding $3 bln in net sales over next five years

Novartis' soon-to-be spun off generics division Sandoz is expected to expand its pipeline and potentially generate an additional $3 billion in net sales over the next five years, the Swiss group said on Thursday.

Related Keywords

London ,City Of ,United Kingdom ,Switzerland ,Swiss ,Himani Sarkar ,Mark Potter ,Natalie Grover ,Thomson Reuters Trust Principles ,Reuters ,Novartis ,Vas Narasimhan ,London Editing ,Thomson Reuters Trust ,Rhpi Mergers Acquisitions ,Bact ,Biz ,Cmpny ,Deal1 ,Dvst ,Gen ,Hea ,Heca ,Phag08 ,Phar ,Phar08 ,Phar1 ,Phmr ,Privt ,Publ ,Ceeu ,Weu ,Europ ,Peach ,Ezc ,Hat ,Fin ,Rhpi Commercial Strategy ,Drugen ,Pres ,Resf ,Topnws ,Mtpix ,Pxp ,Topcmb ,